Physician profile
Brad J Bachmann
NPI 1598861809
$378,171.39
in general payments reported to CMS, 2019-2025
14 companies · $14.94 in 2025
The $14.94 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,246 · 2020: $412 · 2021: $3,287 · 2022: $329K · 2023: $36K · 2024: $8,702 · 2025: $14.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $44K · Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $44,264.88 |
| Food and Beverage | $301.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $372,800.69 | 2022-2024 | Avenger Radial Head, +4 Stems |
| Paragon 28, INC. | $1,557.39 | 2019-2021 | |
| In2bones USA, LLC | $1,411.60 | 2019-2020 | |
| Arthrex, INC. | $1,363.84 | 2021 | |
| Medinc of Texas | $398.77 | 2021-2025 | |
| Stryker Corporation | $195.29 | 2022-2024 | Augment Injectable |
| Horizon Therapeutics Plc | $146.97 | 2019 | |
| Medtronic, INC. | $75.71 | 2023 | Intellis Adaptivestim |
| Musculoskeletal Transplant Foundation INC. | $69.68 | 2021 | |
| Trilliant Surgical LLC. | $46.00 | 2022 | |
| Abbott Laboratories | $35.06 | 2024 | Proclaim |
| Smith+Nephew, INC. | $31.89 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Averitas Pharma INC. | $27.13 | 2023 | Qutenza |
| Orthofix Medical, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Bachmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.